Global Trials In China Rich But Challenging – Wyeth Exec
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Clinical trials in China have much potential and can be rewarding if pharmaceutical companies are willing to overcome challenges such as working with young researchers in China, who may not have much pharmaceutical experience, said Ling Su, Wyeth vice president of clinical research and development for Asia Pacific